Received a "Study May Proceed” letter from the U.S. Food and Drug Administration (FDA ... 3 trial for the first-line ...

Journey Medical Corporation (Nasdaq: DERM) ("Journey Medical” or "the Company”, "we”, or "our”), a commercial-stage ...

Robert F. Kennedy Jr. has vowed to combat "the chronic disease epidemic in this country" in the Trump administration, with ...

The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s ...

Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

GNSC-001 is an investigational, adeno-associated virus gene therapy expressing an optimized form of IL-1Ra. The Food and Drug Administration (FDA) has granted Fast Track designation to GNSC-001 for ...

In the wake of the biggest American political comeback in more than 100 years, stakeholders in the health industry are asking themselves: What ...

At the first sign of a runny nose many people dash out to buy a cold and flu remedy - but soon that might become harder to do ...

Recent developments driving growth in this area make the advanced, AI-supported digitization of pharma pipelines inevitable.

Camphor, a traditional ingredient in South Asian desserts, offers a unique cooling flavor and cultural significance. While ...

Research Triangle Park, North Carolina Saturday, November 9, 2024, 13:00 Hrs [IST] ...